1. Introduction {#s0005}
===============

The ε4 allele of the apolipoprotein E gene (*APOE*), which is the main genetic risk factor for late-onset Alzheimer\'s disease (AD), has also a strong and manifold impact neuroimaging phenotypes ([@bb0240]; [@bb0105]) in cognitively normal subjects. In cognitively intact individuals, carrying the ε4 allele has been shown to exert a dose-dependent influence on amyloid accumulation ([@bb0235]), glucose metabolism ([@bb0230]) and the brain structure at macro- and microscopic levels ([@bb0105]). Effects of *APOE*-ε4 on gray matter have been assessed by many studies ([@bb0065]; [@bb1155]; [@bb8866]; [@bb5555]). A growing body of evidence has also been supporting an association between the *APOE*-ε4 status and white matter (WM) integrity. A review of existing results was included in [@bb0210]. In this recent study, microstructural alterations in WM integrity have been reported in cognitively normal carriers of the ε4 allele using diffusion-weighted imaging (DWI), with the largest differences involving higher mean (MD) and radial (RD) rather than changes in axial diffusivity (AxD), in extended regions including bilateral main associative tracts. Such directional pattern in diffusion metrics has often been regarded as a reflection of potential thinning of the myelin sheath, rather than Wallerian degeneration ([@bb0285]; [@bb0310]; [@bb0260]). Myelin quantification requires the implementation of specific imaging protocols (see [@bb0145] for a recent review). Otherwise, myelination cannot be strictly measured using standard single-shell DWI techniques and can only be speculated through the appreciation of combined diffusivity metrics.

Myelin is produced by oligodendrocytes in the central nervous system and forms an insulating layer around axons, which provides key core functions related to signal transmission. Given the main role of *APOE* in the transport of cholesterol which is a major component of myelin, the observed lower functionality of the ε4 isoform is suspected to contribute to the increased risk to AD observed in ε4-carriers ([@bb0175]).

Impacts of common risk factors on demyelination and its contribution to cognitive decline are suspected but have been poorly investigated in human populations ([@bb0085]; [@bb0220]). Bartzokis and colleagues have introduced a model describing the course of myelin integrity across lifespan, following an inverted U-shape ([@bb0030]), its association with cognitive efficiency metrics ([@bb0185]) and how its breakdown may relate to neuropathological processes such as incipient AD ([@bb0025]; [@bb0035]). Some results have also supported the proposed concept of *retrogenesis,* suggesting that the latest tracts to myelinate would be the most vulnerable to age and pathologies, and therefore the first to disrupt ([@bb0040]; [@bb0115]; [@bb0270]; [@bb0050]; [@bb6655]). AD-related myelin changes have long been considered as secondary aging effects and hence literature on the subject is still lacking. [@bb0090] in a recent study report widespread age-related changes especially in late-myelinating brain regions and negative associations between relaxometry measures across WM and levels of CSF biomarkers in cognitively asymptomatic participants. [@bb0045] showed decreased myelin water fraction in subjects suffering mild cognitive impairment, vascular dementia or AD, compared with old controls. Altogether these results shed light on the role myelin and oligodendrocytes may play in the AD continuum and support a potentially emerging value of myelination as biomarker, in line with the recent attention given to micro- and macrostructural changes in WM in the risk and progression of AD ([@bb0205]).

It has been proposed that the ratio of T1-weighted (T1w) over T2-weighted (T2w) Magnetic Resonance Imaging (MRI) intensities could render myelin-enhanced contrast images ([@bb0125]), which may be well-suited in contexts where specific multi-compartment acquisitions are not available or feasible. The method is based on the assumption that histological measures of myelin content covary with both T1w and T2w intensity, but in opposite directions ([@bb0120]). It was initially proposed for cortical mapping of myelin, then was extended to the whole brain ([@bb0110]) and met a variety of applications with special emphasis in developmental studies ([@bb0170]; [@bb0265]; [@bb0165]), neurodegenerative diseases e.g. MS ([@bb0245]), schizophrenia ([@bb0150]), Alzheimer\'s disease ([@bb0300]; [@bb0215]) and the healthy brain ([@bb0250]).

The present study aims at studying the impact of *APOE*-ε4 allele load on white matter myelin, using T1w/T2w maps as a proxy for myelin content, and its interaction with age. To this end, we generated T1w/T2w ratio maps following the approach introduced by [@bb0120] and performed group analysis using non-parametric skeleton-based statistics focused on WM tracts ([@bb0255]). Such method has been extensively used to explore microstructural changes using diffusion metrics and still to our knowledge has never been employed before for this type of data.

Our initial hypothesis was based on that if previous differences observed with DWI were due to changes in white matter myelination, then those changes would potentially be captured by T1w/T2w maps. We hence hypothesized that subjects at risk of developing AD would show negatively affected ratio values in regions matching the differences observed in diffusion imaging (long associative tracts) ([@bb0210]). The high number of *APOE*-ε4 homozygotes allowed us to better understand the impact of this allele according to the number of carried copies on the microstructural properties of the brain. We assessed the effects of *APOE*-ε4 load, status, age, and sex. We hypothesized that T1w/T2w ratio values would decline with age, as expected with the course of myelination at this age range. Effect of sex was reported for exploratory purposes. Age by genotype interaction was also tested.

2. Methods and materials {#s0010}
========================

2.1. Study participants {#s0015}
-----------------------

The participants of this study were recruited in two steps. In a first phase, 2743 cognitively healthy volunteers aged between 45 and 74 years were registered in the ALFA study (ALzheimer and FAmilies), a large cohort program aimed at identifying neuroimaging biomarkers of preclinical AD in the general population ([@bb0195]). Exclusion criteria included performance below established cutoffs for a number of cognitive tests as well as the presence of any psychiatric or any other clinically significant condition ([@bb0195]). In a second phase, after *APOE* genotyping, cerebral MRI examination was proposed to all participants homozygous (HO) for the ε4 allele and all carriers of the ε2 allele, along with ε4-heterozygous (HT) and non-carriers (NC) matched for age and sex. This strategy resulted in the selection of 576 study participants, 61 of whom had to be excluded because of either MRI incidental findings (32), poor image quality (12) or processing issue (17), resulting in a final sample size of 515. Demographic characteristics of the participants are summarized in [Table 1](#t0005){ref-type="table"}.Table 1Sample characteristics.Table 1Total sample (*N* = 515)NC (*N* = 250)HT (*N* = 197)HO (*N* = 68)Inferential statistics*MSDMSDMSDMSD*Age[a](#tf0005){ref-type="table-fn"}58.007.4158.407.5558.577.3554.946.18F = 6.88; *p* \< .01Education[a](#tf0005){ref-type="table-fn"}13.643.5713.623.6113.753.5313.383.46F = 0.27; *p* = .76MMSE[b](#tf0010){ref-type="table-fn"}29.041.0829.001.1229.021.1029.260.77F = 1.54; *p* = .22TFR[b](#tf0010){ref-type="table-fn"}16.475.1616.235.1516.375.1217.735.12F = 2.24; *p* = .11TPR[b](#tf0010){ref-type="table-fn"}24.114.5023.724.8424.244.2325.193.68F = 2.84; *p* = .06WMH[c](#tf0015){ref-type="table-fn"}3.18 \[1.09, 3.65\]3.22 \[1.13, 3.41\]3.03 \[1.08, 3.70\]3.47 \[1.13, 3.82\]H = 0.60; *p* = .65Fazekas scales**0**: 247 **1**: 221 **2**: 39 **3**:2**0**: 113 **1**: 115 **2**: 17 **3**: 2**0**: 101 **1**: 80 **2**: 14**0**: 33 **1**: 26 **2**: 8χ^2^ = 3.82; *p* = .43Male/female201/31488/16288/10925/43χ^2^ = 4.32; *p* = .12[^2][^3][^4][^5]

For the statistical analyses, participants were pooled according to the cumulative number of ε4 alleles, that is, noncarriers as well as ε4-heterozygous and ε4-homozygous individuals. Since homozygous subjects were significantly younger than noncarriers and heterozygotes ([Table 1](#t0005){ref-type="table"}), age was included as a covariate in all subsequent analyses.

2.2. *APOE* genotyping {#s0020}
----------------------

Total DNA was obtained from the blood cellular fraction by proteinase K digestion followed by alcohol precipitation. Samples were genotyped for two single nucleotide polymorphisms (SNPs), rs429358 and rs7412, determining the possible *APOE* isoforms: ε1, rs429358 (C) + rs7412 (T); ε2, rs429358 (T) + rs7412 (T); ε3, rs429358 (T) + rs7412 (C); and ε4, rs429358 (C) + rs7412 (C). Of the 515 participants, 153 were ε3/ε4 carriers, 146 were homozygous for the ε3 allele, 104 were ε2/ε3 carriers, 68 were homozygous for the ε4 allele and 44 were ε2/ε4. The allele frequencies were in Hardy-Weinberg equilibrium.

2.3. Cognitive measures {#s0025}
-----------------------

The Memory Binding Test (MBT) ([@bb0060]) was used to evaluate verbal episodic memory. This test assesses immediate and delayed retention of verbal information (after a lapse of 25 to 35 min) through a controlled learning process of two lists of 16 words belonging to 16 different semantic categories presented in the same order. Further detail on the administration procedure of the MBT and an exhaustive description of each of the variables can be found in ([@bb0130]). MBT yielded seven main outcomes corresponding to two main areas: learning and immediate recall, and delayed recall. Executive function was assessed by means of five WAIS-IV subtests: the Digit span (immediate and working memory): forward, backward and sequencing; Coding subtest (processing speed and attention); Matrix reasoning and Visual puzzles (fluid intelligence); and Similarities (abstract verbal reasoning). We summarized these scores in two Z scores, one for memory and one for executive functions, by computing arithmetic means of individual Z scores from the original score values.

2.4. Image data acquisition {#s0030}
---------------------------

All brain MRI data were acquired on a single standard 3 T General Electric scanner (GE Discovery MR750 W). Structural 3D high-resolution T1-weighted images were collected in the sagittal plane using a fast spoiled gradient-echo (FSPGR) sequence implementing the following parameters: voxel size = 1 mm^3^ isotropic, Repetition Time \[TR\] = 6.16 ms, Echo Time \[TE\] = 2.33 ms, Inversion Time \[TI\] = 450 ms, matrix size = 256 × 256 × 174, flip angle = 12°. T2 and T2\*-weighted sequences were acquired in the axial plane with a voxel size of 1 × 1 × 3 mm and the following parameters: fluid attenuation inversion recovery (FLAIR: TR/TE/TI = 11,000/90/2600 ms, flip angle = 160°), fast spin echo (TR/TE = 5000/85 ms, flip angle = 110°), and gradient echo (GRE: TR/TE = 1300/23 ms, flip angle = 15°).

The DWI protocol employed a spin-echo echo-planar imaging sequence with one T2-weighted baseline (b = 0), 64 b = 1000 s·mm^−2^ diffusion-weighted volumes acquired with 64 distinct diffusion-encoding directions. The field of view was 256 × 256 mm, and the imaging matrix was 128 × 128 with 56 slices and slice thickness 2 mm, giving 2-mm isotropic voxels.

All scans were visually assessed for quality and incidental findings by a trained neuroradiologist ([@bb0055]). This resulted in the exclusion of ten participants due to the presence of a meningioma, and of 37 participants due to susceptibility, motion artifacts or segmentation problems, resulting in a total of 515 images ready for subsequent analyses.

2.5. Image processing {#s0035}
---------------------

The general workflow included first the generation of individual T1w/T2w maps, then the group analysis over the main fiber tracts of WM.

### 2.5.1. Generation of individual T1w/T2w ratio maps {#s0040}

T1w and T2w images were converted to NIfTI format and analyzed using a similar method as proposed by [@bb0120]. Brain mask extraction was performed on raw T1w images using FSL BET to facilitate subsequent coregistration with T2w images. BET\'s parameters were fine-tuned for every subject so as to achieve correct brain extraction after individual visual inspection. Raw T2w images were then rigidly coregistered over T1 masked images using the ANTs toolbox (using mutual information as cost function) ([@bb0020]) and ratio maps were generated dividing T1 by T2 intensities. Since group analysis is done over a skeletonized version of WM obtained using DWI data, T1w/T2w ratio maps were aligned to DWI b = 0 maps using ANTs elastic coregistration.

### 2.5.2. Creation of the WM skeleton and projection of the data {#s0045}

DWI images were first denoised with the overcomplete local PCA method by [@bb0190], then corrected for eddy current distortions and head motion (using FSL\'s eddy_correct, default parameters). Data analysis was then performed using tools from the FMRIB Software Library software suite ([@bb0160]). Fractional anisotropy (FA), MD, AxD and RD maps were generated using DTIFit that fits a diffusion tensor model at each voxel. The FA output images were used as input for Tract-Based Spatial Statistics (TBSS) ([@bb0255]). TBSS is a pipeline - part of the FSL toolbox - which has been broadly used in DWI studies, including an image processing and statistical analysis part, both carried out consecutively. In this pipeline, intersubject matching is achieved by projecting unsmoothed data on skeletons representing the center of the WM fiber bundles and subsequent statistical analysis is done on the projected data relying on a non-parametric permutation-based technique, hence mitigating some limitations of the standard voxel-based morphometric approach. It consists of the following steps. All subjects\' FA data were coregistered to the FMRIB58 FA template using FMRIB\'s Non-linear Image Registration Tool (FNIRT). The mean FA image was generated and then "thinned", by non-maximum-suppression perpendicular to the local tract structure, to create a mean FA skeleton, which represents the centers of all tracts common to the group. The mean skeleton was thresholded and binarized at FA \> 0.2. T1w/T2w maps were warped to the same intersubject reference space using individual transformations obtained from the coregistration of the FA maps. Each subject\'s aligned data - including FA and T1w/T2w maps - was finally projected onto the mean FA skeleton and the resulting projected data fed into voxelwise group analysis.

2.6. Statistical analysis {#s0050}
-------------------------

Group-related differences were assessed using a voxel by voxel permutation nonparametric test (5000 permutations) with threshold-free cluster enhancement, as performed by the Randomise tool available in FSL ([@bb0295]). All results are shown at *P* \< .05 corrected for multiple comparisons across space. Correction for multiple testing was applied using the default familywise error rate control with threshold-free cluster enhancement as implemented in Randomise and as described elsewhere ([@bb0295]; [@bb7755]).

We performed voxelwise multiple linear regression analysis using two main models, the first one to measure the effect of the number of *APOE-ε4* alleles on skeletonized T1w/T2w maps and the second one which modeled the interaction effect with age on top of the main effect of *APOE* genotype. We partitioned genetic variance by including three dummy regressors coding for the number of ε4 alleles carried. The first model included age and sex as confounding variables (5 regressors in total). The second one only included sex, as age by genotype interaction was the effect of interest. Considering the expected nature of the course of myelination across time, age was modeled as a quadratic term centered at age 50, matching with descriptions from lifespan studies ([@bb8855]; [@bb0305]; [@bb0135]). This second model resulted in a design matrix with 7 regressors, one for sex as covariate, 3 for the dummy-coded *APOE* genotypic groups (NC, HT, HO; main effect) and 3 for the interaction between *APOE* and age^2^ (centered at 50 years).

We compared T1w/T2w ratios to assess the different components of the effects of *APOE* genotype among dominance (ε4 carriers versus non-carriers), recessivity (homozygotes versus others) and additivity (correlation with the number of ε4 alleles carried), in both directions (positive and negative correlations).

2.7. Supplementary analyses {#s0055}
---------------------------

In order to control for potential biasing effects in our dataset and to compare results across modalities, we repeated the analysis using the exact same models/contrasts over parametric maps obtained by DWI on the same participants. The first model (main effect of *APOE*) matches the one used in [@bb0210]. The second one (interaction with age) is the same as the one used with T1w/T2w ratio maps. Results are presented in Appendix A (Supplementary Data).

A complementary analysis was performed to rule out the potential impact of white matter hyperintensities (WMH), both at global and voxel-wise levels. To this end, WMH masks were segmented from fluid-attenuated inversion recovery images of the same individuals using a method described previously ([@bb9955]; [@bb0210]) and any voxel identified as a lesion in any subject of the studied sample was removed from the analysis. A threshold of 0.9 was used on the original probability maps yielded by the segmentation algorithm to generate binary masks which were fed into TBSS to exclude lesion voxels from the analysis. Global effects of WMH load were also assessed by introducing global WMH volumes as confounders in the statistical models. Independently, potential impact of pathological levels of WMH was evaluated by using Fazekas scores instead as confounders.

We also looked for potential associations between T1w/T2w ratio values and cognitive scores assessed by memory and executive tasks. We used different models for each score among total paired recall (TPR), total free recall (TFR), coding subtest (processing speed) and the two Z scores measuring memory and executive functions, respectively, including - for each of these models - age, sex and *APOE* genotype as confounders.

3. Results {#s0060}
==========

3.1. Main effect of age {#s0065}
-----------------------

There was a significant main effect of age on T1w/T2w ratio in the vast majority of the skeletonized WM ([Fig. 1](#f0005){ref-type="fig"}), demonstrating previously well-documented results regarding age-related changes in myelination through late-middle age.Fig. 1Main effect of age on T1w/T2w ratio. A strong negative association was found between age and T1w/T2w ratio in extensive regions. The WM skeleton is shown in green. Supra-threshold clusters are presented in colors from dark red to white (1-*p* \> .95, familywise error rate- and threshold-free cluster enhancement-corrected).Fig. 1

3.2. Main effect of *APOE* genotype {#s0070}
-----------------------------------

We found significant main effects of *APOE*-ε4 on the T1w/T2w maps. [Fig. 2](#f0010){ref-type="fig"} shows the TBSS map for the significant clusters where *APOE*-ε4 carriers displayed decreased values compared with non-carriers in extended regions of the skeletonized WM. These regions included forceps minor, bilateral superior longitudinal fasciculus (SLF), corpus callosum, corona radiata, inferior fronto-occipital fasciculus (IFOF), left inferior longitudinal fasciculus (ILF) and left anterior thalamic radiation (ATR) (tracts from the John Hopkins University Atlas ([@bb0280])). The observed effects reached statistical significance for the dominant and additive models, therefore suggesting significant differences between non-carriers and carriers and also in a dose-dependent manner. Significant clusters in the additive contrast map share a 48% of suprathreshold voxels with the dominant contrast, while the vast majority (\>99%) of voxels from the additive contrast were also significant in the dominant one. [Fig. 3](#f0015){ref-type="fig"} represents these changes between *APOE* groups across fiber tracts.Fig. 2- Effect of the number of *APOE-ε4 alleles* on T1w/T2w (from top to bottom - dominant and additive components) -.no recessive component was observed - only contrast maps associated with lower T1w/T2w in ε4 carriers showed significant voxels. The WM skeleton is shown in green. Supra-threshold clusters are presented in colors from dark red to white (1-p \> .95, familywise error rate- and threshold-free cluster enhancement-corrected).Fig. 2Fig. 3Main effect of the number of *APOE-ε4* alleles on T1w/T2w ratio across fiber tracts. Each bar represents the mean value extracted from the corresponding tract ROI (from the Johns Hopkins University white matter atlas) along with standard error (confidence interval: 95%). Significant tracts are displayed only (*p* \< .05 familywise error rate corrected). NC = *APOE-ε4* Non-carriers; HT = *APOE-ε4* Heterozygous; HO = *APOE-ε4* Homozygous.Fig. 3

3.3. Interaction *APOE* genotype x age {#s0075}
--------------------------------------

We found a significant negative interaction between the number of *APOE-*ε4 alelles and age in extensive bilateral regions of the WM in both the recessive and the additive contrast ([Fig. 4](#f0020){ref-type="fig"}). These regions included, by decreasing order of spatial extent, forceps minor, bilateral SLF, ATR, corona radiata, right IFOF and corpus callosum in both contrasts. Significant clusters in the additive contrast map share a 93% of suprathreshold voxels with the recessive contrast. In these areas ε4 carriers displayed significantly decreased T1w/T2w ratio with respect to non-carriers. This effect was shown to be dose-dependent with respect to the number of ε4 alleles and stronger in ε4 homozygotes compared to the rest of the subjects. [Fig. 5](#f0025){ref-type="fig"} plots values derived from bilateral SLF with respect to age and genotype group (corrected for sex), hence depicting how T1w/T2w ratio taken in SLF depart in homozygotes as compared to other groups.Fig. 4Interaction between age and *APOE-*ε4 on T1w/T2w (from top to bottom - recessive and additive components) -.no dominant component was observed - only contrast maps associated with lower T1w/T2w in ε4 carriers showed significant voxels. The WM skeleton is shown in green. Supra-threshold clusters are presented in colors from dark red to white (1-p \> .95, familywise error rate- and threshold-free cluster enhancement-corrected).Fig. 4Fig. 5Effect of aging and the number of *APOE-ε4* alelles on T1w/T2w ratios (unitless) in the SLF area. Each dot represents a subject (red: ε4 homozygotes \[HO\], orange: ε4 heterozygotes \[HT\], blue: non-carriers \[NC\]). Quadratic regression (by age correcting for sex) is displayed (solid curves) for each *APOE* group.Fig. 5

3.4. Main effect of sex {#s0080}
-----------------------

T1w/T2w ratios were significantly lower in male participants in a limited set of regions ([Fig. 6](#f0030){ref-type="fig"}), mainly in the left hemisphere, including left SLF, ILF and IFOF and part of the forceps major.Fig. 6Main effect of sex (females \> males) on T1w/T2w ratios. The WM skeleton is shown in green. Supra-threshold clusters are presented in colors from dark red to white (1-p \> .95, familywise error rate- and threshold-free cluster enhancement-corrected).Fig. 6

3.5. Association with cognitive performance {#s0085}
-------------------------------------------

We found no significant association between any cognitive score (among TPR, TFR, coding subtest and Z scores for memory/executive functions) and T1w/T2w ratios.

3.6. Effect of vascular factors {#s0090}
-------------------------------

No voxel demonstrated a significant association between any parametric map and global volumes of WM lesions or Fazekas scores in this dataset. Similarly, no global or regional effect of WMH load was detected in these respective complementary analyses.

4. Discussion {#s0095}
=============

Myelin alterations in subjects at risk of developing AD are still understudied to date in comparison to existing literature on microstructural integrity as measured using DWI. In contrast, changes in diffusion metrics have regularly been interpreted as potentially indicating a loss in myelin content in subjects at risk of developing the disease. Still, myelin cannot be measured using standard single-shell DWI, and can only be speculated through the appreciation of combined diffusivity metrics. We hypothesized that subjects at risk of developing AD would show negatively affected ratio values in regions matching the ones observed in diffusion imaging taking T1w/T2w ratios as indirect measures of myelin content. T1w/T2w ratio has been extensively used in previous research as a non-quantitative descriptor of cortical myelination, but rarely in WM studies ([@bb0075]). Results from this present study show significant decreases of this ratio in *APOE*-ε4 carriers in extended regions of the WM in a cognitively normal population. Across all tested models/contrasts, *APOE*-ε4 carriers never showed significant increases of this ratio. The previously described patterns in DWI (increased RD and MD but not AxD) together with similar results in healthy infants ([@bb0080]), support our previous interpretation that such changes would reflect developmental alterations related to myelin content in ε4 cognitively carriers. As speculated in [@bb0210], by lacking functional isoforms of the ApoE protein, ε4 homozygotes may have thinner myelin sheaths than what would correspond to their age. Altered myelination would impact negatively transmission speed and consequently require a higher metabolic consumption to sustain cognitive performance within normality. As a result, and in combination with other metabolic deficits observed in cognitively normal ε4 carriers, these changes might contribute to the increased vulnerability of this group to brain insults associated with AD.

On the other hand, the interaction between *APOE*-ε4 and age observed in the present study can be interpreted as a higher vulnerability of carriers to age-related processes and/or the presence of AD pathological changes. Importantly, differences in T1w/T2w were found significant in both dominant and additive contrasts, suggesting a main effect of the ε4 allele in a dose-dependent manner. Mirroring previous observations made in DWI studies, the effects of *APOE* on this ratio are observed in extensive regions of the white matter. In particular, SLF, known to be primarily affected in AD ([@bb0005]; [@bb0100]; [@bb0225]; [@bb0270]) and in mild cognitive impairment ([@bb0180]; [@bb0010]), was among the tracts showing the strongest association. Some of the largest effects are also found in forceps minor and long associative tracts such as bilateral SLF, ILF, IFOF. Commissural fibers (e.g. corpus callosum and forceps minor) or limbic system tracts (cingulum) tend to show a rather dominant effect. In contrast, associative tracts (SLF, ILF, IFOF) display a more additive one. Associative tracts are also known to be composed of late-myelinating fibers ([@bb0290]), hence potentially more vulnerable ([@bb0040]) according to the retrogenesis model.

We also replicated previous observations from [@bb0210] using the same model/contrasts on DWI data, still without finding any interaction between age and ε4 status in that modality. Several studies reported different age trajectories of DWI metrics across *APOE* groups in cognitively normal participants, in particular in older samples. In this respect, it might be interpreted that T1w/T2w ratio maps show a higher sensitivity as compared to diffusion imaging to detect myelin-related changes. Still, such difference across modalities is open to various possible interpretations: either the measures provided by the two modalities may address the same common entity, e.g. myelination, therefore such difference would indeed reflect a higher sensitivity of T1w/T2w ratio in detecting the onset of demyelination as compared to DWI; or these measures could possibly relate to compounds which are different albeit related, with T1w/T2w consequently capturing the earlier of two sequential events, while effect on DWI would still be independent of age at that current stage. Head to head comparison and the assessment of the longitudinal evolution of these measurements against more specific measurements of myelin content are required to explore further these dynamics.

T1w/T2w ratio was initially proposed as an indirect, non-quantitative, measure of myelin content ([@bb0125]) and rapidly met interest in a substantial amount of studies ([@bb0250]). A number of considerations have also been raised over the years regarding reliability with respect to tailored acquisition protocols ([@bb0095]; [@bb0145]; [@bb0140]), or other factors e.g. tissues or groups with different pathological conditions. Some authors also advocate for bias correction and intensity normalization prior to T1w/T2w ratio calculation ([@bb0110]) in particular to compensate for interscanner variability in the context of multisite studies. We believe that having acquired it on a single scanner on cognitively healthy participants preserves our dataset reasonably from these variations. We also fairly assume that the use of a permutation-based technique for group comparisons is particularly suited to the case of non-quantitative descriptors, which might fail the general statistical assumptions in standard parametric approaches.

Aside from this, to which particular signal issued from myelin content T1w/T2w ratios are sensitive is still being debated as well. Inconsistent correlations with histology, MT ratios ([@bb0015]), multi-echo T2 ([@bb0275]), or relaxometry ([@bb0140]) suggest that T1w/T2w ratio may also be sensitive to additional microstructural properties such as axonal diameter ([@bb0015]) or be driven by external influences, i.e. iron accumulation, calcium content, inflammation or atrophy ([@bb0275]; [@bb0140]). Nevertheless, while it is acknowledged that T1w/T2w ratio is not a specific index of myelin, it may still be recognized as a useful proxy in particular for group comparisons, such as in recent studies in multiple sclerosis ([@bb0200]; [@bb0245]). More research is needed both to better characterize the intimate nature of the T1w/T2w signal and more generally to address the true impact of demyelination in subjects at risk of developing AD.

In the AD continuum, structural markers are known to depart from their normal course long before cognitive decline typically begins. Additional pathological markers, such as cerebrospinal fluid ratios and brain amyloid burden, are thus required in order to screen preclinical subjects among cognitively normal individuals. In this regard, this present study is currently limited by the absence of these markers. Cognitively healthy *APOE*-ε4 homozygotes have been reported to show a significantly higher prevalence of cerebral amyloid pathology. At the mean age of our homozygote group (55 years), approximately 50% of these individuals display abnormal levels of amyloid biomarkers, as compared with only 10% of non-carriers and about 20% of carriers of a single ε4 allele ([@bb0155]). Besides, T1w/T2w ratio might show a positive association with Aβ accumulation ([@bb0035]), according to recent results ([@bb0300]; [@bb0215]). Still, such impact, as it was suggested, would come in a direction contrary to the one we find for the *APOE-ε4* status, therefore pinpointing the strength of the effect in our dataset regardless of the possible underlying amyloid charge. Eventually, access to follow-up information and complementary examination including positron emission tomographic imaging and lumbar puncture ([@bb0195]) will allow us to mitigate this risk and to account for the influence of Aβ pathology and to better stratify our dataset with respect to preclinical AD research criteria.

The major strength of this study lies in having recruited a relatively young, cognitively healthy sample, with a very large number of *APOE*-ε4 homozygotes. This allowed us to study individuals at three levels of risk, thus building on most published studies that compared carriers vs non-carriers. In complement to results obtained on DWI data on the same participants, this present study adds to the emerging evidence that myelination may represent an important biomarker in the earliest stages of AD. This confirms the need for further investigation based on myelin imaging in order to specifically discriminate changes in myelination against other potential alterations in WM. This could resultantly pave the way for new promyelinating therapeutic strategies.

5. Conclusions {#s0100}
==============

Our results show significantly decreased T1w/T2w ratio values in the WM of cognitively healthy carriers of the *APOE* ε4 allele in a dose-dependent manner. Such variations in T1w/T2w ratio are consistent with differential changes previously observed in DWI metrics, giving further support to the interpretation of an alteration of the myelin sheath of axons at a stage preceding axonal loss. Further research involving specific myelin mapping sequences is required in order to decipher the observed discrepancies between T1w/T2w and DWI, and to achieve quantitative comparisons across *APOE-ε4* genotypic groups.

Appendix A. Supplementary data {#s0110}
==============================
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[^1]: The complete list of collaborators of the ALFA Study can be found in the acknowledgements section.

[^2]: NC = *APOE-ε4* Non-carriers; HT = *APOE-ε4* Heterozygous; HO = *APOE-ε4* Homozygous; MMSE = Mini-Mental State Examination score; TPR = Total Paired Recall; TFR = Total Free Recall;; WMH = White Matter Hyperintensities; M = mean; SD = standard deviation.

[^3]: Indicated in years.

[^4]: Cognition data was not available for 15 subjects.

[^5]: Indicated in mL. Mean value is presented along with first and third quartiles. Data was not available for 6 subjects.
